Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0760
E

Failure to Rotate Insulin Injection Sites Results in Medication Errors

North Hollywood, California Survey Completed on 08-01-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that residents were free from significant medication errors by not rotating subcutaneous insulin injection sites as required by physician orders, manufacturer guidelines, and professional standards. For three residents with diabetes, review of medical records and interviews with nursing staff revealed repeated administration of insulin in the same anatomical locations, despite clear orders and policies mandating site rotation. The electronic medication administration record system had the capability to track previous injection sites, yet staff did not utilize this feature to prevent repeated use of the same sites. One resident with type 2 diabetes and diabetic neuropathy received multiple insulin injections in the same abdominal quadrants over several weeks, as documented in the Location of Administration Report. Both the registered nurse and assistant director of nursing confirmed that this practice did not follow the physician's orders or facility policy, and acknowledged that it constituted a medication error. Similar findings were observed for two other residents, one with end-stage renal disease and metabolic encephalopathy, and another with severe cognitive impairment and total dependence for activities of daily living. In each case, insulin was administered repeatedly in the same areas, and staff interviews confirmed that site rotation was not performed as required. Facility policies and procedures, as well as manufacturer guidelines for both insulin aspart and insulin glargine, were reviewed and all specified the necessity of rotating injection sites to prevent adverse effects. The failure to rotate sites was consistently identified by nursing leadership and staff as a medication error, as it did not comply with physician orders, manufacturer instructions, or accepted professional standards. Documentation requirements for injection site assessment were also outlined in facility policy, but the records reviewed indicated non-compliance with these standards.

An unhandled error has occurred. Reload 🗙